By Laura Donnelly2000-10-19T00:00:00
A typicals for treating schizophrenia received the thumbs-up at an HSJ debate, but some condemned trials backing their use. Laura Donnelly was there
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud